Evidence map›Paper›PMID 40858731›Full record

ArticleScientific reports2025

Comparison of the number of peripapillary perforating scleral vessels between glaucomatous eyes and healthy eyes.

Satoko Fujimoto, Kazuichi Maruyama, Takashi Nishida, Akira Tanikawa, Yuri Iwamoto, Shiyi Liu, Zhenguo Wang, Nobuhiko Shiraki, Kenji Matsushita, Masahiro Akiba and 1 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Satoko FujimotoDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan.
Kazuichi MaruyamaDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan. kazuichi.maruyama@ophthal.med.osaka-u.ac.jp.
Takashi NishidaShiley Eye Institute, University of California, San Diego, US.
Akira TanikawaDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan.
Yuri IwamotoDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan.
Shiyi LiuTopcon Advanced Biomedical Imaging Laboratory, Oakland, NJ, USA.
Zhenguo WangTopcon Advanced Biomedical Imaging Laboratory, Oakland, NJ, USA.
Nobuhiko ShirakiDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan.
Kenji MatsushitaDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan.
Masahiro AkibaTopcon, Tokyo, Japan.
Kohji NishidaDepartment of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan. knishida@ophthal.med.osaka-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to compare the number of peripapillary perforating scleral vessels (PPSVs) between eyes with and without glaucoma. A retrospective case-control analysis was performed on patients with glaucoma and control participants who underwent swept-source optical coherence tomography (SS-OCT) at a single institution. The number of PPSVs around the optic disc was counted on deep-learning assisted en face SS-OCT images created from 6 × 6 mm

Indexed as

GlaucomaOptic DiskScleraAgedCase-Control StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesROC CurveTomography, Optical CoherenceDeep learningGlaucomaPerforating scleral vesselsPeripapillary perforating scleral vesselsRetinal microvasculature

Identifiers

PMID40858731
PMCPMC12381102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.